Next Article in Journal
Tracking the Interplay between Bound Peptide and the Lid Domain of DnaK, Using Molecular Dynamics
Next Article in Special Issue
Oximes: Inhibitors of Human Recombinant Acetylcholinesterase. A Structure-Activity Relationship (SAR) Study
Previous Article in Journal
Human Chorionic Gonadotropin Beta Subunit Genes CGB1 and CGB2 are Transcriptionally Active in Ovarian Cancer
Previous Article in Special Issue
Molecular Dynamics Simulation of Tryptophan Hydroxylase-1: Binding Modes and Free Energy Analysis to Phenylalanine Derivative Inhibitors
Article

Design, Synthesis, Biological Activity and Molecular Dynamics Studies of Specific Protein Tyrosine Phosphatase 1B Inhibitors over SHP-2

1
Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, No.22 of Qixiangtai Road, Heping, Tianjin 300070, China
2
Tianjin Institute of Pharmaceutical Research (TIPR), Tianjin 300193, China
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Int. J. Mol. Sci. 2013, 14(6), 12661-12674; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms140612661
Received: 15 April 2013 / Revised: 2 June 2013 / Accepted: 3 June 2013 / Published: 17 June 2013
Over expressing in PTPN1 (encoding Protein tyrosine phosphatase 1B, PTP1B), a protein tyrosine phosphatase (PTP) that plays an overall positive role in insulin signaling, is linked to the pathogenesis of diabetes and obesity. The relationship between PTP1B and human diseases exhibits PTP1B as the target to treat these diseases. In this article, small weight molecules of the imidazolidine series were screened from databases and optimized on silicon as the inhibitors of PTP1B based on the steric conformation and electronic configuration of thiazolidinedione (TZD) compounds. The top three candidates were tested using an in vitro biological assay after synthesis. Finally, we report a novel inhibitor, Compound 13, that specifically inhibits PTP1B over the closely related phosphatase Src homology 2 (SH2) domain-containing phosphatase 2 (SHP-2) at 80 μΜ. Its IC50 values are reported in this paper as well. This compound was further verified by computer analysis for its ability to combine the catalytic domains of PTP1B and SHP-2 by molecular dynamics (MD) simulations. View Full-Text
Keywords: PTP1B; SHP-2; synthesis; imidazolidine; activity; molecular dynamics PTP1B; SHP-2; synthesis; imidazolidine; activity; molecular dynamics
Show Figures

MDPI and ACS Style

Sun, S.-X.; Li, X.-B.; Liu, W.-B.; Ma, Y.; Wang, R.-L.; Cheng, X.-C.; Wang, S.-Q.; Liu, W. Design, Synthesis, Biological Activity and Molecular Dynamics Studies of Specific Protein Tyrosine Phosphatase 1B Inhibitors over SHP-2. Int. J. Mol. Sci. 2013, 14, 12661-12674. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms140612661

AMA Style

Sun S-X, Li X-B, Liu W-B, Ma Y, Wang R-L, Cheng X-C, Wang S-Q, Liu W. Design, Synthesis, Biological Activity and Molecular Dynamics Studies of Specific Protein Tyrosine Phosphatase 1B Inhibitors over SHP-2. International Journal of Molecular Sciences. 2013; 14(6):12661-12674. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms140612661

Chicago/Turabian Style

Sun, Su-Xia, Xiao-Bo Li, Wen-Bo Liu, Ying Ma, Run-Ling Wang, Xian-Chao Cheng, Shu-Qing Wang, and Wei Liu. 2013. "Design, Synthesis, Biological Activity and Molecular Dynamics Studies of Specific Protein Tyrosine Phosphatase 1B Inhibitors over SHP-2" International Journal of Molecular Sciences 14, no. 6: 12661-12674. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms140612661

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop